INBX
Inhibrx Inc
Price:  
15.12 
USD
Volume:  
63,549.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INBX WACC - Weighted Average Cost of Capital

The WACC of Inhibrx Inc (INBX) is 7.7%.

The Cost of Equity of Inhibrx Inc (INBX) is 8.55%.
The Cost of Debt of Inhibrx Inc (INBX) is 9.30%.

Range Selected
Cost of equity 7.20% - 9.90% 8.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 11.60% 9.30%
WACC 6.2% - 9.2% 7.7%
WACC

INBX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.73 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.91 0.91
Cost of debt 7.00% 11.60%
After-tax WACC 6.2% 9.2%
Selected WACC 7.7%